Autopsy report · NCT00509756
Study Evaluating FXR-450 in Healthy Japanese Men
Cause of deathNo reason given
“Please see termination statement in the detailed description.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 3 months before it stopped.
- 56 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Sponsor type
- Industry
- Conditions
- Healthy
- Interventions
- FXR-450; Placebo
- Participants
- 56
- Sites
- 1
- Countries
- Japan
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.